- Home
- TSBX vs CNVS Comparison
TSBX vs CNVS Comparison
Compare TSBX & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBX
- CNVS
- Stock Information
- Founded
- TSBX 2015
- CNVS 2000
- Country
- TSBX United States
- CNVS United States
- Employees
- TSBX N/A
- CNVS N/A
- Industry
- TSBX
- CNVS Consumer Electronics/Video Chains
- Sector
- TSBX
- CNVS Consumer Discretionary
- Exchange
- TSBX Nasdaq
- CNVS Nasdaq
- Market Cap
- TSBX 7.7M
- CNVS N/A
- IPO Year
- TSBX 2023
- CNVS 2003
- Fundamental
- Price
- TSBX $0.36
- CNVS $5.70
- Analyst Decision
- TSBX Buy
- CNVS Buy
- Analyst Count
- TSBX 3
- CNVS 1
- Target Price
- TSBX $4.75
- CNVS $10.00
- AVG Volume (30 Days)
- TSBX 490.8K
- CNVS 341.6K
- Earning Date
- TSBX 08-13-2025
- CNVS 06-27-2025
- Dividend Yield
- TSBX N/A
- CNVS N/A
- EPS Growth
- TSBX N/A
- CNVS N/A
- EPS
- TSBX N/A
- CNVS 0.16
- Revenue
- TSBX N/A
- CNVS $78,181,000.00
- Revenue This Year
- TSBX N/A
- CNVS N/A
- Revenue Next Year
- TSBX N/A
- CNVS N/A
- P/E Ratio
- TSBX N/A
- CNVS $35.31
- Revenue Growth
- TSBX N/A
- CNVS 59.13
- 52 Week Low
- TSBX $0.29
- CNVS $0.72
- 52 Week High
- TSBX $2.70
- CNVS $5.65
- Technical
- Relative Strength Index (RSI)
- TSBX 51.79
- CNVS 88.16
- Support Level
- TSBX $0.33
- CNVS $3.72
- Resistance Level
- TSBX $0.38
- CNVS $5.31
- Average True Range (ATR)
- TSBX 0.03
- CNVS 0.33
- MACD
- TSBX -0.00
- CNVS 0.15
- Stochastic Oscillator
- TSBX 50.17
- CNVS 100.00
About TSBX Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.